(Q42991028)

12 November 2017

Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation (English)

1 reference

12 November 2017

1 reference

liver transplantation

1 reference

2

1 reference

12 November 2017

Gabriele Molteni

10

0 references

Fabrizio Di Benedetto

Fabrizio Di Benedetto

5

0 references

Fabrizio Di Francesco

Fabrizio Di Francesco

9

0 references

Giovanni Ramacciato

Giovanni Ramacciato

12

0 references

Antonio Daniele Pinna

14

Antonio Daniele Pinna

1 reference

12 November 2017

8

Alessandro Dazzi

1 reference

12 November 2017

4

Michele Masetti

1 reference

12 November 2017

7

Giuliano La Barba

1 reference

12 November 2017

6

Nicola Cautero

1 reference

12 November 2017

13

Andrea Risaliti

1 reference

12 November 2017

Nicola De Ruvo

1

1 reference

PubMed ID

15740564

12 November 2017

Augusto Lauro

3

1 reference

PubMed ID

15740564

12 November 2017

Antonio Romano

11

1 reference

12 November 2017

1 April 2005

1 reference

12 November 2017

Clinical Transplantation

1 reference

12 November 2017

19

1 reference

12 November 2017

2

1 reference

12 November 2017

255-258

1 reference

Host and donor risk factors before and after liver transplantation that impact HCV recurrence

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Impact of immunosuppressive therapy on recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Transplantation tolerance from a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Tolerogenic immunosuppression for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Hepatitis C virus kinetics during and immediately after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00333.X

10.1111/J.1399-0012.2005.00333.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

15740564